National Comprehensive Cancer Network

New Research in JNCCN Evaluates Cost-Effectiveness of Olaparib, a PARP Inhibitor, for Metastatic Pancreatic Cancer

New research in the November 2020 issue of JNCCN identifies metastatic pancreatic cancer patient subgroups with the highest relative cost-effectiveness from maintenance olaparib, a PARP inhibitor.

Announcement

NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development

October 27, 2020 sarah Jonas National Comprehensive Cancer Network, NCCN

The National Comprehensive Cancer Network® (NCCN®) today announced the addition of Beth Gaffney, MBA, as the new Vice President of U.S. and Global Business Development, overseeing licensing and other collaborations.

Announcement

Expert Breast Cancer Treatment Recommendations Based on Latest Evidence Updating for Multiple Languages

October 5, 2020 sarah Jonas Breast Cancer, Breast Cancer Awareness Month, mBC, Metastatic Breast Cancer, National Comprehensive Cancer Network, NCCN, nccn guidelines, Patient Information, Translation

Ongoing updates are underway for NCCN Guidelines for Breast Cancer in Chinese, English, French, Japanese, Korean, Spanish, Polish, and Portuguese, free online at NCCN.org/global. Follow #NCCNGlobal for more. The NCCN Foundation is hosting free metastatic breast cancer webinars for patients and caregivers on October 8 and 12 at NCCN.org/patients.

Policy

New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma

September 28, 2020 sarah Jonas Blood Cancer, Childhood Cancer, Clinical Practice Guidelines, Hematologic Cancers, hematologic malignancies, Hematology, National Comprehensive Cancer Network, NCCN, nccn guidelines, Pediatric Cancer, pediatric Hodgkin lymphoma

The National Comprehensive Cancer Network announces publication of new NCCN Guidelines for Pediatric Hodgkin Lymphoma, one of the most curable forms of pediatric cancer. They synthesize the latest evidence and expert-consensus to make sure every child receives appropriate, but not excessive, treatment.

Announcement

New NCCN Resource for Understanding Childhood Leukemia

September 23, 2020 sarah Jonas Acute Lymphoblastic Leukemia, Blood Cancer, Childhood Cancer, Childhood Cancer Awareness Month, Hematologic Cancers, hematologic malignancies, Leukemia, National Comprehensive Cancer Network, NCCN, NCCN Foundation, nccn guidelines, NCCN Guidelines for Patients, Pediatric Acute Lymphoblastic Leukemia, pediatric acute lymphoblastic leukemia (ALL), Pediatric ALL, pediatric leukemia

NCCN publishes a new patient and caregiver resource focused on a childhood cancer type. Free NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia (ALL) shares the latest expert advice for treating infants, children, and adolescents with the most common pediatric malignancy.

Policy

NCCN Policy Summit Explores How to Lower Costs for Cancer Care

September 9, 2020 sarah Jonas Health Policy, Healthcare Costs, National Comprehensive Cancer Network, NCCN

NCCN Virtual Policy Summit features congressional staffers and representatives from CMS, COA, BIO, and others, discussing legislative and regulatory approaches for reducing health care costs.

Research Results

New Research in JNCCN Sheds Light on Multi-Organ Adverse Events from Immunotherapy

September 8, 2020 sarah Jonas Adverse Events, immune checkpoint inhibitors, Immunotherapy, jnccn, JNCCN - Journal of the National Comprehensive Cancer Network, multi-organ damage, National Comprehensive Cancer Network, NCCN

New international research in the September 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds immunotherapy-related adverse events (irAEs) can impact more than one organ in a single patient. Multi-organ irAEs are more likely to happen sequentially rather than simultaneously.

Announcement

Up-to-Date Leading Cancer Treatment Recommendations from NCCN Now Available in Chinese

September 3, 2020 sarah Jonas China, Chinese, Clinical Guidelines, National Comprehensive Cancer Network, NCCN, NCCN Global, nccn guidelines

NCCN announces new and updated Chinese language versions of NCCN Guidelines for AML, Breast Cancer, CLL/SLL, Colon Cancer, Gastric Cancer, Hairy Cell Leukemia, Head and Neck Cancers, Hodgkin Lymphoma, Melanoma (Cutaneous), Multiple Myeloma, Non-small Cell Lung Cancer, Primary Cutaneous Lymphomas, and T-Cell Lymphomas.

Announcement

NCCN Meeting on Blood Cancers Will Be Virtual for the First Time

August 27, 2020 sarah Jonas Blood Cancers, CE, CME, CME credit, CMEs, Continuing Education, continuing education credits, Continuing Medical Education, Hematologic Cancers, hematologic malignancies, hematologic oncology, HEME, Leukemia, Lymphoma, National Comprehensive Cancer Network, NCCN, nccn guidelines, Oncology Nursing

The NCCN Virtual Nursing Forum and Annual Congress: Hematologic Malignancies (#NCCNhem2020) will provide the latest evidence and expert consensus on emerging practices and debates in blood cancer treatment, online October 8-10.

Announcement

NCCN Oncology Research Program Announces Projects Selected for Funding to Study Futibatinib in Tumors with Aberrant FGFR Expression, in Collaboration with Taiho Oncology

July 23, 2020 sarah Jonas FGFR, National Comprehensive Cancer Network, NCCN, nccn oncology research program, NCCN orp

The NCCN Oncology Research Program (ORP) today announced four projects selected to receive funding for clinical and pre-clinical evaluation of futibatinib (TAS-120) in collaboration with Taiho Oncology.

Announcement

NCCN Explores Adoption of Biosimilars in Oncology in Collaboration with Pfizer

July 15, 2020 sarah Jonas biosimilars, Clinical Trial, Funding, National Comprehensive Cancer Network, NCCN, nccn oncology research program, NCCN orp, oncology research

National Comprehensive Cancer Network issues Request for Proposals (RFP) for projects that develop and validate enduring approaches to improve the safe, effective, and efficient adoption of biosimilars in oncology.

Announcement

Translated Tool from NCCN Measures Mental Health “Temperature” of People with Cancer

July 13, 2020 sarah Jonas Cancer And Depression, Mental Health, National Comprehensive Cancer Network, NCCN, NCCN Global, nccn guidelines, Psychiatiry, Psychology

The NCCN Distress Thermometer enables discussion and treatment of distress as part of routine care for people with cancer. This free resource is now translated into 46 languages for global accessibility.

← Previous